Pancreatic pathology: where are we in 2019?
Pancreatic ductal adenocarcinoma (PDAC) takes centre stage in the field of pancreatic pathology. It is the most common pancreatic neoplasm and carries a dismal prognosis with rising mortality rates. Tissue diagnosis focuses on the identification of PDAC and its distinction from non-neoplastic disorders such as chronic pancreatitis and rarer, less aggressive pancreatic neoplasms. Pathology also plays a key role in the assessment of well characterized macroscopic precursor lesions of PDAC: mucinous cystic neoplasms and intraductal papillary mucinous neoplasms.
Source: Surgery (Medicine Publishing) - Category: Surgery Authors: Beate Haugk, Shreya Raman, Yvonne Bury Tags: Basic science Source Type: research
More News: Adenocarcinoma | Pancreas | Pancreatic Cancer | Pancreatitis | Pathology | Science | Surgery